Antioxidant peptide A
目录号 : GC34392AntioxidantpeptideA是一种短肽。作用于癌细胞时,AntioxidantpeptideA的侧链有助于增强自由基清除活性。
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Kinase experiment: | Y79 cells are seeded at 2×105 cells/well in 12-well plates with 1000 μL of culture media and incubated at 37°C overnight. The cells are then exposed to varying dosages of Antioxidant peptide A (Pep-A) and Pep-B (10, 50, and 100 μM) in fresh medium and then incubated for 6 h. At the end of the incubation, the cells are collected and washed with ice-cold PBS twice and lysed with cell lysis buffer [0.1 M Tris/HCl, pH 7.4 containing 0.5 % Triton X-100, 5 mM β-Mercaptoethanol, 0.1 mg/mL PMSF]. Cell lysate is centrifuged at 14000×g for 5 min at 4°C. The supernatant contains a combined SOD activity from cytosol and mitochondria. The SOD activity is measured using the superoxide dismutase (SOD) activity assay kit. In brief, the cell lysate, buffer, enzyme, and the WST reagent are diluted, and the solution is added as per the protocol and incubated at 37°C for 20 min and read at 450 nm on a microplate reader. SOD activity is then calculated as a percentage of the inhibition activity of xanthine oxidase[1]. |
Cell experiment: | Y79 retinoblastoma and MIOM1 cells are seeded at 5×103 cells/well in 96-well plates and incubated at 37°C overnight. The cells are then treated with varying concentrations (10, 30, 60, and 100 µM) of Antioxidant peptide A (Pep-A) and Pep-B in a fresh medium and incubated for specific time periods (24 and 48 h). At the end of the incubation, 10 µL of MTT (5 mg/mL) is added to the cells with fresh medium (100 µL) and incubated at 37°C until formazan crystals are formed. The formazan crystals are dissolved in 100 µL of DMSO, and the reading is taken at 570 nm. Cell viability is calculated[1]. |
References: [1]. Kalmodia S, et al. Bio-conjugation of antioxidant peptide on surface-modified gold nanoparticles: a novel approach to enhance the radical scavenging property in cancer cell. Cancer Nanotechnol. 2016;7:1. |
Antioxidant peptide A is a short peptide, which contains alternative aromatic or sulfur-containing amino acid. The side chains of Antioxidant peptide A are believed to contribute to strong radical scavenging activities of peptides in the cancer cell.
The effects of 10-100 μM of Antioxidant peptide A (Pep-A) concentrations are studied on the superoxide dismutase (SOD) enzyme activity. The enzyme activity decreases by 0.5 and 0.7-folds at 10 and 50 µM Antioxidant peptide A concentrations, respectively, and increases by 1.79-folds at 100 µM Antioxidant peptide A treatment, indicating that this concentration can be ideal for the treatment on Y79 a, RB cells. Furthermore, the Antioxidant peptide A can be involved in decreasing the ROS by increasing the antioxidant enzyme activity. A similar increase in the antioxidative enzyme levels in the presence of Hoki skin antioxidative peptide in hepatocarcinoma cells is attributed to the peptide's role in maintaining the redox balance in the cellular environment. Cell viability analysis results show that the Antioxidant peptide A shows no toxicity to cancerous (Y79) cells and non-cancerous cells even after 48 h of treatment. The Y79 RB cell viability ranges between 115 and 157 % and 111-126 % after 24 and 48 h of exposures with Antioxidant peptide A, respectively. The cancer cell death from the treatment of 10-100 µM GNPs concentration is studied[1].
[1]. Kalmodia S, et al. Bio-conjugation of antioxidant peptide on surface-modified gold nanoparticles: a novel approach to enhance the radical scavenging property in cancer cell. Cancer Nanotechnol. 2016;7:1.
Cas No. | SDF | ||
Canonical SMILES | Pro-His-Cys-Lys-Arg-Met | ||
分子式 | C31H54N12O7S2 | 分子量 | 770.97 |
溶解度 | Soluble in Water | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.2971 mL | 6.4853 mL | 12.9707 mL |
5 mM | 0.2594 mL | 1.2971 mL | 2.5941 mL |
10 mM | 0.1297 mL | 0.6485 mL | 1.2971 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。